Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q
Front Microbiol. 2025; 16:1504395.
PMID: 39944642
PMC: 11814227.
DOI: 10.3389/fmicb.2025.1504395.
Forkan C, Shrestha A, Yu A, Chuang C, Pociot F, Yarani R
Stem Cell Res Ther. 2025; 16(1):37.
PMID: 39901225
PMC: 11792614.
DOI: 10.1186/s13287-025-04153-4.
Nazir A, Uwishema O, Shariff S, Franco W, El Masri N, Ayele N
Health Sci Rep. 2024; 7(11):e70136.
PMID: 39502130
PMC: 11535861.
DOI: 10.1002/hsr2.70136.
Kim E, Choi J, Jang H, Kim Y, Lee J, Ryu Y
Theranostics. 2024; 14(10):3777-3792.
PMID: 38994018
PMC: 11234275.
DOI: 10.7150/thno.97755.
Almohaimeed H, Almars A, Alsulaimani F, Basri A, Althobaiti N, Albalaw A
Front Aging Neurosci. 2024; 16:1379431.
PMID: 38867846
PMC: 11168113.
DOI: 10.3389/fnagi.2024.1379431.
The Association of Micro-RNA 21 and Hypertension: A Meta-Analysis.
Xin C, He W, Sun X, Li M, Wang H
Glob Heart. 2024; 19(1):41.
PMID: 38708403
PMC: 11067968.
DOI: 10.5334/gh.1325.
miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling.
Rawal S, Randhawa V, Rizvi S, Sachan M, Wara A, Perez-Cremades D
Cardiovasc Res. 2024; 120(14):1693-1712.
PMID: 38703377
PMC: 11587565.
DOI: 10.1093/cvr/cvae102.
MiRNA-21a, miRNA-145, and miRNA-221 Expression and Their Correlations with WNT Proteins in Patients with Obstructive and Non-Obstructive Coronary Artery Disease.
Iusupova A, Pakhtusov N, Slepova O, Belenkov Y, Privalova E, Bure I
Int J Mol Sci. 2023; 24(24).
PMID: 38139440
PMC: 10744268.
DOI: 10.3390/ijms242417613.
Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis.
Chaube B, Citrin K, Sahraei M, Singh A, Saenz de Urturi D, Ding W
Nat Commun. 2023; 14(1):8251.
PMID: 38086791
PMC: 10716292.
DOI: 10.1038/s41467-023-43900-0.
Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review.
Kim T, Kim Y, Jung W, Jang S, Ko H, Park C
Biomolecules. 2023; 13(11).
PMID: 38002328
PMC: 10669845.
DOI: 10.3390/biom13111646.
Is miR-21 A Therapeutic Target in Cardiovascular Disease?.
Holland A, Enrick M, Diaz A, Yin L
Int J Drug Discov Pharm. 2023; 2(1):26-36.
PMID: 37799562
PMC: 10552863.
DOI: 10.53941/ijddp.0201003.
MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.
Li Z, Zhao Y, Suguro S, Suguro R
Oxid Med Cell Longev. 2023; 2023:2561509.
PMID: 37675243
PMC: 10480027.
DOI: 10.1155/2023/2561509.
Evaluation of microRNA Expression Features in Patients with Various Types of Arterial Damage: Thoracic Aortic Aneurysm and Coronary Atherosclerosis.
Ekedi A, Rozhkov A, Shchekochikhin D, Novikova N, Kopylov P, Bestavashvili A
J Pers Med. 2023; 13(7).
PMID: 37511774
PMC: 10381304.
DOI: 10.3390/jpm13071161.
Inflammatory microRNAs in cardiovascular pathology: another brick in the wall.
Zapata-Martinez L, Aguila S, de Los Reyes-Garcia A, Carrillo-Tornel S, Lozano M, Gonzalez-Conejero R
Front Immunol. 2023; 14:1196104.
PMID: 37275892
PMC: 10233054.
DOI: 10.3389/fimmu.2023.1196104.
The Role of ncRNAs in Cardiac Infarction and Regeneration.
Cano-Carrillo S, Lozano-Velasco E, Castillo-Casas J, Sanchez-Fernandez C, Franco D
J Cardiovasc Dev Dis. 2023; 10(3).
PMID: 36975887
PMC: 10052289.
DOI: 10.3390/jcdd10030123.
Genetic dissection of the impact of lncRNA AI662270 during the development of atherosclerosis.
Hong Y, Zhang Y, Chen H, Tang X, Zhao H, Meng Z
J Transl Med. 2023; 21(1):97.
PMID: 36755320
PMC: 9906833.
DOI: 10.1186/s12967-023-03962-6.
MicroRNAs in Macrophages: Regulators of Activation and Function.
Sprenkle N, Serezani C, Pua H
J Immunol. 2023; 210(4):359-368.
PMID: 36724439
PMC: 10316964.
DOI: 10.4049/jimmunol.2200467.
The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review.
Teixeira A, Vaz Ferreira V, Pereira-da-Silva T, Ferreira R
Front Cardiovasc Med. 2022; 9:1040971.
PMID: 36505351
PMC: 9733725.
DOI: 10.3389/fcvm.2022.1040971.
Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease.
Kablak-Ziembicka A, Badacz R, Przewlocki T
J Clin Med. 2022; 11(22).
PMID: 36431326
PMC: 9698927.
DOI: 10.3390/jcm11226849.
Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.
Canfran-Duque A, Rotllan N, Zhang X, Andres-Blasco I, Thompson B, Sun J
Circulation. 2022; 147(5):388-408.
PMID: 36416142
PMC: 9892282.
DOI: 10.1161/CIRCULATIONAHA.122.059062.